Report Detail
Global Antibody Drug Conjugates Market Professional Survey Report 2019
- RnM3796234 |
- 01 October, 2019 |
- Global |
- 105 Pages |
- QYResearch |
- Pharma & Healthcare
Antibody Drug Conjugates are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment.
The preparation process of ADC’s involves great difficulty, inspite of these hurdles recently approved ADC’s have proved their worth for treatment of cancer. Thus, there is a strong pipeline of ADC’s that promises revolutionary changes in area of targeted therapy for cancer treatment. This market is driven by elements such as continuous improvement in the clinical data and technological advancements in the field of drug development shelling out innovative drugs into the market.
The global Antibody Drug Conjugates market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Antibody Drug Conjugates volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antibody Drug Conjugates market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Antibody Drug Conjugates in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Antibody Drug Conjugates manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
F. Hoffman-La Roche
Novartis AG
Takeda Pharmaceutical
Pfizer
Seattle Genetics
Genentech
Immunogen
Progenics Pharmaceuticals
Bayer Healthcare Pharmaceuticals
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Adcetris
Kadcyla
Segment by Application
Breast Cancer
Lymphoma
Table of Contents
Executive Summary
1 Industry Overview of Antibody Drug Conjugates
- 1.1 Definition of Antibody Drug Conjugates
- 1.2 Antibody Drug Conjugates Segment by Type
- 1.2.1 Global Antibody Drug Conjugates Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Adcetris
- 1.2.3 Kadcyla
- 1.3 Antibody Drug Conjugates Segment by Applications
- 1.3.1 Global Antibody Drug Conjugates Consumption Comparison by Applications (2014-2025)
- 1.3.2 Breast Cancer
- 1.3.3 Lymphoma
- 1.4 Global Antibody Drug Conjugates Overall Market
- 1.4.1 Global Antibody Drug Conjugates Revenue (2014-2025)
- 1.4.2 Global Antibody Drug Conjugates Production (2014-2025)
- 1.4.3 North America Antibody Drug Conjugates Status and Prospect (2014-2025)
- 1.4.4 Europe Antibody Drug Conjugates Status and Prospect (2014-2025)
- 1.4.5 China Antibody Drug Conjugates Status and Prospect (2014-2025)
- 1.4.6 Japan Antibody Drug Conjugates Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Antibody Drug Conjugates Status and Prospect (2014-2025)
- 1.4.8 India Antibody Drug Conjugates Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Antibody Drug Conjugates
- 2.3 Manufacturing Process Analysis of Antibody Drug Conjugates
- 2.4 Industry Chain Structure of Antibody Drug Conjugates
3 Development and Manufacturing Plants Analysis of Antibody Drug Conjugates
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Antibody Drug Conjugates Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Antibody Drug Conjugates
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Antibody Drug Conjugates Production and Capacity Analysis
- 4.2 Antibody Drug Conjugates Revenue Analysis
- 4.3 Antibody Drug Conjugates Price Analysis
- 4.4 Market Concentration Degree
5 Antibody Drug Conjugates Regional Market Analysis
- 5.1 Antibody Drug Conjugates Production by Regions
- 5.1.1 Global Antibody Drug Conjugates Production by Regions
- 5.1.2 Global Antibody Drug Conjugates Revenue by Regions
- 5.2 Antibody Drug Conjugates Consumption by Regions
- 5.3 North America Antibody Drug Conjugates Market Analysis
- 5.3.1 North America Antibody Drug Conjugates Production
- 5.3.2 North America Antibody Drug Conjugates Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Antibody Drug Conjugates Import and Export
- 5.4 Europe Antibody Drug Conjugates Market Analysis
- 5.4.1 Europe Antibody Drug Conjugates Production
- 5.4.2 Europe Antibody Drug Conjugates Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Antibody Drug Conjugates Import and Export
- 5.5 China Antibody Drug Conjugates Market Analysis
- 5.5.1 China Antibody Drug Conjugates Production
- 5.5.2 China Antibody Drug Conjugates Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Antibody Drug Conjugates Import and Export
- 5.6 Japan Antibody Drug Conjugates Market Analysis
- 5.6.1 Japan Antibody Drug Conjugates Production
- 5.6.2 Japan Antibody Drug Conjugates Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Antibody Drug Conjugates Import and Export
- 5.7 Southeast Asia Antibody Drug Conjugates Market Analysis
- 5.7.1 Southeast Asia Antibody Drug Conjugates Production
- 5.7.2 Southeast Asia Antibody Drug Conjugates Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Antibody Drug Conjugates Import and Export
- 5.8 India Antibody Drug Conjugates Market Analysis
- 5.8.1 India Antibody Drug Conjugates Production
- 5.8.2 India Antibody Drug Conjugates Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Antibody Drug Conjugates Import and Export
6 Antibody Drug Conjugates Segment Market Analysis (by Type)
- 6.1 Global Antibody Drug Conjugates Production by Type
- 6.2 Global Antibody Drug Conjugates Revenue by Type
- 6.3 Antibody Drug Conjugates Price by Type
7 Antibody Drug Conjugates Segment Market Analysis (by Application)
- 7.1 Global Antibody Drug Conjugates Consumption by Application
- 7.2 Global Antibody Drug Conjugates Consumption Market Share by Application (2014-2019)
8 Antibody Drug Conjugates Major Manufacturers Analysis
- 8.1 F. Hoffman-La Roche
- 8.1.1 F. Hoffman-La Roche Antibody Drug Conjugates Production Sites and Area Served
- 8.1.2 F. Hoffman-La Roche Product Introduction, Application and Specification
- 8.1.3 F. Hoffman-La Roche Antibody Drug Conjugates Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Novartis AG
- 8.2.1 Novartis AG Antibody Drug Conjugates Production Sites and Area Served
- 8.2.2 Novartis AG Product Introduction, Application and Specification
- 8.2.3 Novartis AG Antibody Drug Conjugates Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Takeda Pharmaceutical
- 8.3.1 Takeda Pharmaceutical Antibody Drug Conjugates Production Sites and Area Served
- 8.3.2 Takeda Pharmaceutical Product Introduction, Application and Specification
- 8.3.3 Takeda Pharmaceutical Antibody Drug Conjugates Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Pfizer
- 8.4.1 Pfizer Antibody Drug Conjugates Production Sites and Area Served
- 8.4.2 Pfizer Product Introduction, Application and Specification
- 8.4.3 Pfizer Antibody Drug Conjugates Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Seattle Genetics
- 8.5.1 Seattle Genetics Antibody Drug Conjugates Production Sites and Area Served
- 8.5.2 Seattle Genetics Product Introduction, Application and Specification
- 8.5.3 Seattle Genetics Antibody Drug Conjugates Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Genentech
- 8.6.1 Genentech Antibody Drug Conjugates Production Sites and Area Served
- 8.6.2 Genentech Product Introduction, Application and Specification
- 8.6.3 Genentech Antibody Drug Conjugates Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Immunogen
- 8.7.1 Immunogen Antibody Drug Conjugates Production Sites and Area Served
- 8.7.2 Immunogen Product Introduction, Application and Specification
- 8.7.3 Immunogen Antibody Drug Conjugates Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Progenics Pharmaceuticals
- 8.8.1 Progenics Pharmaceuticals Antibody Drug Conjugates Production Sites and Area Served
- 8.8.2 Progenics Pharmaceuticals Product Introduction, Application and Specification
- 8.8.3 Progenics Pharmaceuticals Antibody Drug Conjugates Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Bayer Healthcare Pharmaceuticals
- 8.9.1 Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Production Sites and Area Served
- 8.9.2 Bayer Healthcare Pharmaceuticals Product Introduction, Application and Specification
- 8.9.3 Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
9 Development Trend of Analysis of Antibody Drug Conjugates Market
- 9.1 Global Antibody Drug Conjugates Market Trend Analysis
- 9.1.1 Global Antibody Drug Conjugates Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Antibody Drug Conjugates Regional Market Trend
- 9.2.1 North America Antibody Drug Conjugates Forecast 2019-2025
- 9.2.2 Europe Antibody Drug Conjugates Forecast 2019-2025
- 9.2.3 China Antibody Drug Conjugates Forecast 2019-2025
- 9.2.4 Japan Antibody Drug Conjugates Forecast 2019-2025
- 9.2.5 Southeast Asia Antibody Drug Conjugates Forecast 2019-2025
- 9.2.6 India Antibody Drug Conjugates Forecast 2019-2025
- 9.3 Antibody Drug Conjugates Market Trend (Product Type)
- 9.4 Antibody Drug Conjugates Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Antibody Drug Conjugates Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Antibody Drug Conjugates. Industry analysis & Market Report on Antibody Drug Conjugates is a syndicated market report, published as Global Antibody Drug Conjugates Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Antibody Drug Conjugates market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
